Treatment with 24 h-delayed normo- and hyperbaric oxygenation in severe sepsis induced by cecal ligation and puncture in rats

大鼠盲肠结扎穿刺诱发的严重脓毒症中,延迟24小时进行常压和高压氧治疗

阅读:1

Abstract

BACKGROUND: Septic shock remains a leading cause of death worldwide. Hyperbaric oxygen treatment (HBO(2)) has been shown to alter the inflammatory response during sepsis and to reduce mortality. A therapeutic window of HBO(2) treatment has been demonstrated experimentally, but optimal timing remains uncertain. We investigated the effects of 24 h delayed normobaric oxygen (NBO(2)) and HBO(2) treatment on the endogenous production of the inflammatory markers interleukin (IL)-6, tumor necrosis factor (TNF)-α and IL-10, and on mortality in rats with cecal ligation and puncture (CLP) induced sepsis. METHOD: Fifty-five male Sprague-Dawley rats underwent CLP and were randomized to the following groups: 1) HBO(2) 2.5 bar absolute pressure (p(abs)); 2) NBO(2) 1.0 bar p(abs); 3) Control (no-treatment), and they were individually monitored for 72 h with intermittent blood sampling. RESULTS: IL-6, TNF-α, and IL-10 were increased 24 h after the procedure, and IL-6 was significantly higher in non-survivors than in survivors. The level of IL-10 was significantly higher at hour 48 in the HBO(2) group compared to control (p = 0.01), but this was not the case at other time points. No other significant differences in cytokine levels were found for any group comparisons. Delayed NBO(2) and HBO(2) treatment failed to change the mortality in the animals. CONCLUSION: High levels of IL-6 in non-surviving animals with sepsis suggest that IL-6 is a potential biomarker. We found a significantly higher concentration of IL-10 in the HBO(2) group at hour 48 vs. control animals. However, 24 h-delayed treatment with HBO(2) did not change the levels of pro-inflammatory cytokines and survival, suggesting that earlier intervention may be required to obtain an anti-inflammatory effect.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。